125 related articles for article (PubMed ID: 36753369)
21. Identification of a seven-gene signature predicting clinical outcome of liver cancer based on tumor mutational burden.
Cui Y; Jiang N
Hum Cell; 2022 Jul; 35(4):1192-1206. PubMed ID: 35622212
[TBL] [Abstract][Full Text] [Related]
22. Identification and Validation of a Novel Six-Gene Expression Signature for Predicting Hepatocellular Carcinoma Prognosis.
Yan Z; He M; He L; Wei L; Zhang Y
Front Immunol; 2021; 12():723271. PubMed ID: 34925311
[TBL] [Abstract][Full Text] [Related]
23. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
Zhao QJ; Zhang J; Xu L; Liu FF
World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
[TBL] [Abstract][Full Text] [Related]
24. Identification of metabolism genes related to hepatocarcinogenesis and progression in type 2 diabetes mellitus via co-expression networks analysis.
Bi Y; Yin B; Fan G
Hereditas; 2021 Apr; 158(1):14. PubMed ID: 33865459
[TBL] [Abstract][Full Text] [Related]
25. Development and Validation of an Autophagy-Related Gene Signature for Predicting the Prognosis of Hepatocellular Carcinoma.
Zhang J; Zhang M; Huang J; Zhang G; Li C; Wang X; Kong W
Biomed Res Int; 2021; 2021():7771037. PubMed ID: 34746309
[TBL] [Abstract][Full Text] [Related]
26. A novel prognostic models for identifying the risk of hepatocellular carcinoma based on epithelial-mesenchymal transition-associated genes.
Xiong C; Wang G; Bai D
Bioengineered; 2020 Dec; 11(1):1034-1046. PubMed ID: 32951492
[TBL] [Abstract][Full Text] [Related]
27. Correlation analysis of tumor mutation burden of hepatocellular carcinoma based on data mining.
Zhou W; Fang D; He Y; Wei J
J Gastrointest Oncol; 2021 Jun; 12(3):1117-1131. PubMed ID: 34295561
[TBL] [Abstract][Full Text] [Related]
28. Identification of Potential Hub Genes Related to Diagnosis and Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma via Integrated Bioinformatics Analysis.
Tang Y; Zhang Y; Hu X
Biomed Res Int; 2020; 2020():4251761. PubMed ID: 33376723
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of Ribosomal Protein S6 Kinase A4 (RPS6KA4) Predicts a Poor Prognosis in Hepatocellular Carcinoma Patients: A Study Based on TCGA Samples.
Lu Y; Ren X; Zhou C; Chen H; Fan Y; Wang C
Comb Chem High Throughput Screen; 2022; 25(13):2165-2179. PubMed ID: 35232347
[TBL] [Abstract][Full Text] [Related]
30. Identification of an Oxidative Stress-Related LncRNA Signature for Predicting Prognosis and Chemotherapy in Patients With Hepatocellular Carcinoma.
Zhong Z; Xu M; Tan J
Pathol Oncol Res; 2022; 28():1610670. PubMed ID: 36277962
[No Abstract] [Full Text] [Related]
31. Bioinformatic Analysis to Identify a Multi-mRNA Signature for the Prediction of Metastasis in Hepatocellular Carcinoma.
Liu L; Wang B; Han Q; Zhen C; Li J; Qu X; Wang F; Kong X; Zheng L
DNA Cell Biol; 2020 Nov; 39(11):2028-2039. PubMed ID: 33147069
[TBL] [Abstract][Full Text] [Related]
32. MARCKS on Tumor-Associated Macrophages is Correlated with Immune Infiltrates and Poor Prognosis in Hepatocellular Carcinoma.
Ren X; Ju Y; Wang C; Wei R; Sun H; Zhang Q
Cancer Invest; 2021 Oct; 39(9):756-768. PubMed ID: 34279157
[TBL] [Abstract][Full Text] [Related]
33. Construction of a risk score prognosis model based on hepatocellular carcinoma microenvironment.
Zhang FP; Huang YP; Luo WX; Deng WY; Liu CQ; Xu LB; Liu C
World J Gastroenterol; 2020 Jan; 26(2):134-153. PubMed ID: 31969776
[TBL] [Abstract][Full Text] [Related]
34. Pyroptosis related genes signature predicts prognosis and immune infiltration of tumor microenvironment in hepatocellular carcinoma.
Fang G; Zhang Q; Fan J; Li H; Ding Z; Fu J; Wu Y; Zeng Y; Liu J
BMC Cancer; 2022 Sep; 22(1):999. PubMed ID: 36127654
[TBL] [Abstract][Full Text] [Related]
35. Identification of immune infiltration-related genes as prognostic indicators for hepatocellular carcinoma.
Dai K; Liu C; Guan G; Cai J; Wu L
BMC Cancer; 2022 May; 22(1):496. PubMed ID: 35513781
[TBL] [Abstract][Full Text] [Related]
36. Predicting the prognosis of hepatocellular carcinoma based on the interaction between pyroptosis, apoptosis, and necroptosis.
Qian F; Kong W; Wang S; Wei K
Clin Exp Med; 2023 Oct; 23(6):2087-2104. PubMed ID: 36271962
[TBL] [Abstract][Full Text] [Related]
37. Integrated analysis of ferroptosis-related gene signature for overall survival prediction in Asian patients with hepatocellular carcinoma.
Wang Z; Zhang L; Xu J; Song W
Clin Transl Oncol; 2023 Mar; 25(3):721-730. PubMed ID: 36319928
[TBL] [Abstract][Full Text] [Related]
38. Identification of chromatin organization-related gene signature for hepatocellular carcinoma prognosis and predicting immunotherapy response.
Chen J; Chen X; Li T; Wang L; Lin G
Int Immunopharmacol; 2022 Aug; 109():108866. PubMed ID: 35691273
[TBL] [Abstract][Full Text] [Related]
39. Identification of CFHR4 as a Potential Prognosis Biomarker Associated With lmmune Infiltrates in Hepatocellular Carcinoma.
Yu H; Wang C; Ke S; Bai M; Xu Y; Lu S; Feng Z; Qian B; Xu Y; Zhou M; Li Z; Yin B; Li X; Hua Y; Zhou Y; Pan S; Fu Y; Ma Y
Front Immunol; 2022; 13():892750. PubMed ID: 35812416
[TBL] [Abstract][Full Text] [Related]
40. Screening and identification of angiogenesis-related genes as potential novel prognostic biomarkers of hepatocellular carcinoma through bioinformatics analysis.
Zhen Z; Shen Z; Hu Y; Sun P
Aging (Albany NY); 2021 Jul; 13(13):17707-17733. PubMed ID: 34252885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
